Synthesis of a diverse library of mechanism-based cysteine protease inhibitors

被引:19
作者
Wood, WJL [1 ]
Huang, L [1 ]
Ellman, JA [1 ]
机构
[1] Univ Calif Berkeley, Dept Chem, Ctr New Direct Organ Synth, Berkeley, CA 94720 USA
来源
JOURNAL OF COMBINATORIAL CHEMISTRY | 2003年 / 5卷 / 06期
关键词
D O I
10.1021/cc034008r
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
We report improvements of our method for the solid-phase synthesis of mechanism-based mercaptomethyl ketone inhibitors of cysteine proteases (Lee, A.; Huang, L.; Ellman, J. A. J. Am. Chem. Soc. 1999, 121, 9907-9914). Specifically, Fmoc-protected chloromethyl ketones were used, rather than the Alloc-protected counterparts. In addition, we further demonstrated that diverse polar functionality can be incorporated at the R-1', R-1, and R-2 sites, in contrast to our previous efforts, where primarily hydrophobic groups were incorporated at these positions. On the basis of these results, a 2016-membered library of potential mercaptomethyl ketone inhibitors was prepared that incorporated diverse functionality. The library was screened against cathepsin B, which is implicated in cancer, resulting in the identification of single-digit nanomolar inhibitors. Because of the diverse functionality incorporated in this library, it should be a rich source of potent inhibitors against many other cysteine proteases.
引用
收藏
页码:869 / 880
页数:12
相关论文
共 29 条
[1]  
AMORIM DS, 1979, TRYPANOSOMA CRUZI DO, P265
[2]  
BARRETT AJ, 1981, METHOD ENZYMOL, V80, P535
[3]  
BUNIN BA, 1998, COMBINATORIAL INDEX, V17, P219
[4]   Characterization of the substrate specificity of the major cysteine protease (cruzipain) from Trypanosoma cruzi using a portion-mixing combinatorial library and fluorogenic peptides [J].
DelNery, E ;
Juliano, MA ;
Meldal, M ;
Svendsen, I ;
Scharfstein, J ;
Walmsley, A ;
Juliano, L .
BIOCHEMICAL JOURNAL, 1997, 323 :427-433
[5]   THE DETERMINATION OF ENZYME INHIBITOR CONSTANTS [J].
DIXON, M .
BIOCHEMICAL JOURNAL, 1953, 55 (01) :170-171
[6]   Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts [J].
Drake, FH ;
Dodds, RA ;
James, IE ;
Connor, JR ;
Debouck, C ;
Richardson, S ;
LeeRykaczewski, E ;
Coleman, L ;
Rieman, D ;
Barthlow, R ;
Hastings, G ;
Gowen, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (21) :12511-12516
[7]   Rapid and general profiling of protease specificity by using combinatorial fluorogenic substrate libraries [J].
Harris, JL ;
Backes, BJ ;
Leonetti, F ;
Mahrus, S ;
Ellman, JA ;
Craik, CS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (14) :7754-7759
[8]   Identification of potent and selective mechanism-based inhibitors of the cysteine protease cruzain using solid-phase parallel synthesis [J].
Huang, L ;
Lee, A ;
Ellman, JA .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (03) :676-684
[9]   Chemical proteomics and its application to drug discovery [J].
Jeffery, DA ;
Bogyo, M .
CURRENT OPINION IN BIOTECHNOLOGY, 2003, 14 (01) :87-95
[10]   PEPTIDYL (ACYLOXY)METHYL KETONES AND THE QUIESCENT AFFINITY LABEL CONCEPT - THE DEPARTING GROUP AS A VARIABLE STRUCTURAL ELEMENT IN THE DESIGN OF INACTIVATORS OF CYSTEINE PROTEINASES [J].
KRANTZ, A ;
COPP, LJ ;
COLES, PJ ;
SMITH, RA ;
HEARD, SB .
BIOCHEMISTRY, 1991, 30 (19) :4678-4687